Scottsdale Institute Renews Bid for Drug Production Permit
Published Date: 2/18/2025
Notice
Summary
Scottsdale Research Institute wants permission to make large amounts of certain controlled drugs. This affects anyone tracking or regulating these substances and could impact drug research and supply. Keep an eye out for official decisions and deadlines that might change how these drugs are handled.
Analyzed Economic Effects
1 provisions identified: 0 benefits, 0 costs, 1 mixed.
Bulk Controlled‑Substance Manufacturing Application
Scottsdale Research Institute has applied to be registered as a bulk manufacturer of basic classes of controlled substances. This filing affects people and organizations who track or regulate controlled drugs and could affect drug research and supply. Watch for the agency's supplementary information, official decisions, and deadlines that may change how these drugs are handled.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in